MicroRNA‐200a suppresses prostate cancer progression through BRD4/AR signaling pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MicroRNA‐200a suppresses prostate cancer progression through BRD4/AR signaling pathway

Published:2019-02-19 Issue:4 Volume:8 Page:1474-1485
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Guan Han¹^ORCID,You Zonghao²,Wang Can²,Fang Fang³,Peng Rui⁴,Mao Likai⁵,Xu Bin²,Chen Ming²

Affiliation:

1. Department of Urology The First Affiliated Hospital of Bengbu Medical College Bengbu China

2. Department of Urology Affliated Zhongda Hospital of Southeast University Nanjing China

3. Department of Immunology Bengbu Medical College Bengbu China

4. Department of Graduate School Bengbu Medical College Bengbu China

5. Department of Urology The Second Affiliated Hospital of Bengbu Medical College Bengbu China

Funder

Bengbu Medical College

National Natural Science Foundation of China

Natural Science Foundation of Anhui Province

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2029

Reference38 articles.

1. Cancer treatment and survivorship statistics, 2016

2. Cancer statistics, 2018

3. Integrative Clinical Genomics of Advanced Prostate Cancer

4. Interleukin-6 and prostate cancer progression

5. MicroRNA and cancer

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism of BRD4 Inhibitor-Mediated c-MYC Expression and Regulation of AR Expression to Inhibit Prostate Cancer;Journal of Biomedical Nanotechnology;2024-07-01

2. Molecular landscape for risk prediction and personalized therapeutics of castration-resistant prostate cancer: at a glance;Frontiers in Endocrinology;2024-06-03

3. n6-methyladenosine-modified circular RNA family with sequence similarity 126, member A affects cholesterol synthesis and malignant progression of prostate cancer cells by targeting microRNA-505-3p to mediate calnexin;Journal of Cancer;2024

4. Diverse roles of miRNAs in breast cancer and gynecologic cancers;MicroRNA in Human Infectious Diseases;2024

5. MicroRNAs as biomarkers for early diagnosis, targeting and prognosis of prostate cancer;Pathology - Research and Practice;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3